Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De CvfiledCriticalAlparis Sa De Cv
Priority to MX2013015100ApriorityCriticalpatent/MX349971B/en
Publication of MX2013015100ApublicationCriticalpatent/MX2013015100A/en
Publication of MX349971BpublicationCriticalpatent/MX349971B/en
The present invention refers to a synergistic combination of lercanidipine and/or the pharmaceutically acceptable salts thereof and aliskiren and/or the pharmaceutically acceptable salts thereof, as well as the composition comprising said combination, the invention also referring to the use of said combination for preparing a drug to be administered along with one or more pharmaceutically acceptable excipients for the control and/or prevention and/or treatment of hypertension and related disorders. In addition, different physico-chemically stable, safe, efficient and effective compositions comprising the synergistic combination are protected, as well as the manufacturing process and different pharmaceutical administration forms.
MX2013015100A2013-12-182013-12-18Synergistic combination for treating hypertension.
MX349971B
(en)